Catalyst Wire Dossier Catalyst Wire Dossier

Vedolizumab (Entyvio)

Vedolizumab · Takeda
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Vedolizumab (Entyvio), covering 2025-02-12 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]

See pricing